SCHEMBL573192

SCHEMBL573192

CCC=CCCOC(=O)CC(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 2/20 0.41
NR1I2 O75469 1/20 0.41
PGR P06401 1/20 0.41
PTGS2 P35354 1/20 0.41
PDE4D Q08499 1/20 0.41
ALDH1A1 P00352 4/20 0.39
TSHR P16473 2/20 0.39
CYP3A4 P08684 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 2/20 0.36
CYP19A1 P11511 2/20 0.36
RXRA P19793 2/20 0.36
PPARG P37231 2/20 0.36
OXER1 Q8TDS5 2/20 0.36
FFAR1 O14842 1/20 0.36
PRKCA P17252 1/20 0.36
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8580784 1.00 ADORA3 (0.41) ADORA3NR1I2PGRPTGS2PDE4D
SCHEMBL573191 1.00 ADORA3 (0.41) ADORA3NR1I2PGRPTGS2PDE4D
SCHEMBL29980849 0.88 PRKCA (0.33) ADORA3NR1I2PGRPTGS2PDE4D
SCHEMBL5898820 0.82 ADORA3 (0.36) ADORA3NR1I2PGRPTGS2PDE4D
SCHEMBL5898818 0.82 ADORA3 (0.36) ADORA3NR1I2PGRPTGS2PDE4D
SCHEMBL20912984 0.81 SLC1A3 (0.37) ADORA3NR1I2PGRPTGS2PDE4D
SCHEMBL17075354 0.81 PRKCA (0.37) ADORA3NR1I2PGRPTGS2PDE4D
SCHEMBL17075355 0.81 PRKCA (0.37) ADORA3NR1I2PGRPTGS2PDE4D
SCHEMBL22832723 0.80 ADORA3 (0.55) ADORA3NR1I2PGRPTGS2PDE4D
SCHEMBL22832722 0.80 ADORA3 (0.55) ADORA3NR1I2PGRPTGS2PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250295826-A1 FRAGRANCES AS UREASE INHIBITORS SYMRISE AG (DE) 2025-09-25 US claimed
CN-118716595-B Lotus seed essence and preparation method thereof 广东馨杰生化科技有限公司 2025-02-11 CN claimed
EP-4496468-A1 FRAGRANCES AS UREASE INHIBITORS Symrise AG (DE) 2025-01-29 EP claimed
CN-119053683-A 1-Norbornan-2-yl-propan-2-one as a fragrance 西姆莱斯股份公司 2024-11-29 CN claimed
CN-118716595-A Lotus seed essence and preparation method thereof 广东馨杰生化科技有限公司 2024-10-01 CN claimed
WO-2023179884-A1 FRAGRANCES AS UREASE INHIBITORS SYMRISE AG (DE) 2023-09-28 WO claimed
CN-112438427-B Cigarette blasting bead containing fruity mint essence, implantation device and method 山东中烟工业有限责任公司 2022-09-09 CN claimed
EP-3809876-A1 PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME PERPRIN S.R.L. (IT) 2021-04-28 EP claimed
EP-3801449-A1 ORAL CARE COMPOSITION WITH IMPROVED DEPOSITION EFFICACY OF A COOLING SENSATE AGENT IN THE ORAL CAVITY The Procter & Gamble Company (US) 2021-04-14 EP claimed
CN-112438427-A Fruity mint essence for cigarette bead blasting, implanting device and method 山东中烟工业有限责任公司 2021-03-05 CN claimed
US-20160089464-A1 MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed
US-20160090557-A1 SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed
US-20160090555-A1 CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed
WO-2016049389-A1 MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
WO-2016049404-A1 SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 WO claimed
US-20160090556-A1 PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed
US-20160089317-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 US claimed
US-20140135297-A1 AQUEOUS VOLATILE ORGANIC COMPOUND FREE DISINFECTANT AND/OR CLEANING COMPOSITION AND METHOD OF PREPARATION ISP INVESTMENTS INC. (US) 2014-05-15 US claimed
US-4954077-A LIQUIFIED BUTANE GAS CONTAINING PERFUME TAMURA TAKEMI (JP) 1990-09-04 US claimed
EP-0313428-A1 Gas lighter Tamura, Takemi (JP) 1989-04-26 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160089317-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS LPO, QDPR, TYR ADORA3 2556/4885NR1I2 1139/4885PGR 2228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.